Engaging the public about the promise of cancer immunotherapy Community Hub Engaging the public about the promise of cancer immunotherapy Dr Alison Halliday Jul 27, 2018
Q&A with Pramodkumar P Gupta Community Hub Q&A with Pramodkumar P Gupta Dr Alison Halliday Jul 10, 2018
Nature Conference on Inflammation and Cancer Community Hub Nature Conference on Inflammation and Cancer Dr Alison Halliday Jul 04, 2018
Patent opportunities for monoclonal antibody inventions Community Hub Patent opportunities for monoclonal antibody inventions Dr Alison Halliday Jun 14, 2018
Immunotherapy shows promise for breast cancer Community Hub Immunotherapy shows promise for breast cancer Dr Alison Halliday Jun 05, 2018
Research Highlights: A perfect match Community Hub Research Highlights: A perfect match Dr Alison Halliday May 03, 2018
Film: Cancer Immunotherapy - a patient's story Community Hub Film: Cancer Immunotherapy - a patient's story Dr Alison Halliday Apr 11, 2018
Film: Tumour Immunology and Immunotherapy Community Hub Film: Tumour Immunology and Immunotherapy Dr Alison Halliday Apr 04, 2018
Film: Immunology wars - Monoclonal antibodies Community Hub Film: Immunology wars - Monoclonal antibodies Dr Alison Halliday Mar 28, 2018
Member Q+A - Dr Chih-Chien Chou Community Hub Member Q+A - Dr Chih-Chien Chou Dr Alison Halliday Mar 16, 2018
Widening the benefits of immune checkpoint inhibitors Community Hub Widening the benefits of immune checkpoint inhibitors Dr Alison Halliday Mar 14, 2018
Weekly round-up – what are members discussing? Community Hub Weekly round-up – what are members discussing? Dr Alison Halliday Mar 12, 2018
Member Q+A - Dr Saman Maleki Community Hub Member Q+A - Dr Saman Maleki Dr Alison Halliday Mar 09, 2018
How our genes, microbiome and environment can influence the cancer-immune setpoint Community Hub How our genes, microbiome and environment can influence the cancer-immune setpoint Dr Alison Halliday Mar 07, 2018
How a tumour's genetics influences the cancer-immune setpoint Community Hub How a tumour's genetics influences the cancer-immune setpoint Dr Alison Halliday Feb 28, 2018
Member Q&A - Dr Stergios Doumas Community Hub Member Q&A - Dr Stergios Doumas Dr Alison Halliday Feb 23, 2018
Immunovirotherapies - a powerful combination? Community Hub Immunovirotherapies - a powerful combination? Dr Alison Halliday Feb 21, 2018
Member Q+A - Mohamed H.S. Awwad Community Hub Member Q+A - Mohamed H.S. Awwad Dr Alison Halliday Feb 16, 2018
Analysis of the clinical immuno-oncology landscape Community Hub Analysis of the clinical immuno-oncology landscape Dr Alison Halliday Feb 14, 2018
Showcasing members of our community Community Hub Showcasing members of our community Dr Alison Halliday Feb 12, 2018
Member Q+A - Dr Abhishek D. Garg Community Hub Member Q+A - Dr Abhishek D. Garg Dr Alison Halliday Feb 09, 2018
Cancer immunity: A mission to the moon Community Hub Cancer immunity: A mission to the moon Dr Alison Halliday Feb 05, 2018
Q&A – with Dr Alba Gonzalez-Junca Community Hub Q&A – with Dr Alba Gonzalez-Junca Dr Alison Halliday Feb 02, 2018
Meet the men behind the framework Community Hub Meet the men behind the framework Dr Alison Halliday Jan 31, 2018
This week's member activity Community Hub This week's member activity Dr Alison Halliday Jan 28, 2018
What's the vision for the framework? Community Hub What's the vision for the framework? Dr Alison Halliday Jan 24, 2018
Round up of member activity Community Hub Round up of member activity Dr Alison Halliday Jan 22, 2018
How to post - a quick reminder Community Hub How to post - a quick reminder Dr Alison Halliday Jan 17, 2018
Introducing your new Community Manager Community Hub Introducing your new Community Manager Dr Alison Halliday Jan 17, 2018
